NEW YORK, NY, Doctronic, the first AI system legally authorized to practice medicine in the United States, today announced a $40 million Series B round.
The round was co-led by Abstract and Lightspeed Venture Partners, with participation from existing investors including Union Square Ventures, Seven Stars, Mantis, and Tusk Ventures. The financing-Doctronic's third round in less than 12 months-brings total funding to more than $65 million.
Doctronic is the first AI system legally authorized to practice medicine in the United States. Built on a collective intelligence architecture, Doctronic provides free personalized health insights and connects users to licensed providers instantly, affordably, and securely. The company is headquartered in New York City and available across all 50 states.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.